Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | XIAP | P98170 | 1/20 | 0.45 |
| ▸ | CAPN1 | P07384 | 4/20 | 0.44 |
| ▸ | REN | P00797 | 1/20 | 0.44 |
| ▸ | ACE | P12821 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | NTSR2 | O95665 | 3/20 | 0.42 |
| ▸ | NTSR1 | P30989 | 3/20 | 0.42 |
| ▸ | CMA1 | P23946 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | GRB2 | P62993 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5065494 | 0.93 | XIAP (0.48) | SLC6A2XIAPCAPN1RENNTSR2 | |
| SCHEMBL5065490 | 0.93 | XIAP (0.48) | SLC6A2XIAPCAPN1RENNTSR2 | |
| SCHEMBL29883844 | 0.91 | OPRM1 (0.50) | OPRM1SLC6A2XIAPCAPN1REN | |
| SCHEMBL29351166 | 0.90 | KMT2A (0.51) | SLC6A2XIAPCAPN1KMT2ANTSR2 | |
| SCHEMBL31083914 | 0.89 | ACE (0.56) | RENACEKMT2A | |
| SCHEMBL30586507 | 0.89 | SLC6A2 (0.57) | OPRM1SLC6A2XIAPRENCMA1 | |
| SCHEMBL3857343 | 0.88 | CAPN1 (0.51) | SLC6A2CAPN1RENKMT2ANTSR2 | |
| SCHEMBL3857337 | 0.88 | CAPN1 (0.51) | SLC6A2CAPN1RENKMT2ANTSR2 | |
| SCHEMBL29592298 | 0.88 | KEAP1 (0.46) | OPRM1SLC6A2CAPN1RENACE | |
| SCHEMBL32681284 | 0.88 | CAPN1 (0.53) | OPRM1SLC6A2XIAPCAPN1REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |